New report highlights access gap for innovative medicines

The CAH Support Group recently provided input into a new Medicines Australia report about access to innovative medicines in Australia.
The report, now published, warns that Australian patients are missing access to some innovative medicines available in comparable countries (including medicines for babies with CAH), citing funding pressures and lengthy reimbursement processes as key factors.
Read the full report here:
https://www.medicinesaustralia.com.au/wp-content/uploads/sites/65/2026/07/03826-MA-BitterPill-Report_Accessible_Final.pdf
(Summary and title image generated using AI)Recent Blog Posts
Webinar: Quality of life and fertility in CAH – 21st November 2026
In this free webinar, join experts across Europe discussing quality of life and fertility in CAH.
Supporting Safer Adrenal Crisis Care
The Addison’s Disease Self-Help Group (ADSHG) has launched a national advocacy campaign to improve emergency treatment and patient safety for people at risk of adrenal crisis. The campaign was sparked by the discontinuation of liquid hydrocortisone in the UK, which...
Pituitary Awareness Month (October) – Symptoms in the Spotlight
Read more at this link…


